The DoD Global, Laboratory-based, Influenza Surveillance Program: summary for the 2013-2014 influenza season
- PMID: 27030925
The DoD Global, Laboratory-based, Influenza Surveillance Program: summary for the 2013-2014 influenza season
Abstract
This report for the 2013-2014 influenza season summarizes the results of influenza surveillance carried out by the DoD Global, Laboratory-based, Influenza Surveillance Program, which is managed by the U.S. Air Force School of Aerospace Medicine Epidemiology Consult Service and Epidemiology Laboratory at Wright-Patterson Air Force Base, OH. Sentinel sites submitted 3,903 specimens for clinical diagnostic testing and 1,163 (29.8%) were positive for influenza virus. The predominant influenza subtype was influenza A(H1N1)pdm09, identified in 79.2% of all influenza-positive specimens. The other most common subtypes were influenza A(H3N2) (10.5%) and influenza B (10.1%). In August 2014, a human case of influenza A(H3N2) variant was identified in a patient with a history of exposure to swine. Adjusted vaccine effectiveness (VE) was calculated among 1,016 military dependents and retirees in the U.S. and was found to be 44.8% for all vaccine types. Uncertainties and other limitations associated with estimating VE are discussed.
Similar articles
-
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139. Euro Surveill. 2016. PMID: 26924024
-
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.Clin Infect Dis. 2012 Aug;55(3):332-42. doi: 10.1093/cid/cis431. Epub 2012 Apr 26. Clin Infect Dis. 2012. PMID: 22539661
-
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.J Infect Dis. 2015 Sep 1;212(5):726-39. doi: 10.1093/infdis/jiv177. Epub 2015 Mar 17. J Infect Dis. 2015. PMID: 25784728
-
Surveillance snapshot: Influenza vaccine effectiveness, U.S. European Command, as estimated by the Department of Defense Global, Laboratory-Based Influenza Surveillance Program, 2016-2017 influenza season.MSMR. 2017 Oct;24(10):22. MSMR. 2017. PMID: 29077424 Review. No abstract available.
-
Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic.BMC Public Health. 2011 Mar 4;11 Suppl 2(Suppl 2):S6. doi: 10.1186/1471-2458-11-S2-S6. BMC Public Health. 2011. PMID: 21388566 Free PMC article. Review.
Cited by
-
Surveillance outcomes of respiratory pathogen infections during the 2021-2022 season among U.S. Military Health System beneficiaries, October 3, 2021-October 1, 2022.MSMR. 2024 May 20;31(5):16-23. MSMR. 2024. PMID: 38857490 Free PMC article.
-
Post-pandemic influenza-associated mortality in Mexico.Pathog Glob Health. 2019 Mar;113(2):67-74. doi: 10.1080/20477724.2019.1589211. Epub 2019 Mar 21. Pathog Glob Health. 2019. PMID: 30895882 Free PMC article.
-
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):643-645. doi: 10.15585/mmwr.mm6722a5. MMWR Morb Mortal Wkly Rep. 2018. PMID: 29879095 Free PMC article.
-
Establishment and evaluation of a theater influenza monitoring platform.Mil Med Res. 2017 Nov 20;4(1):35. doi: 10.1186/s40779-017-0144-3. Mil Med Res. 2017. PMID: 29502518 Free PMC article.
-
Live Attenuated and Inactivated Influenza Vaccine Effectiveness.Pediatrics. 2019 Feb;143(2):e20182094. doi: 10.1542/peds.2018-2094. Epub 2019 Jan 7. Pediatrics. 2019. PMID: 30617239 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical